Susquehanna International Group, LLP Y M Abs Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$6.57 - $18.69 $37,941 - $107,934	5,775 Added 34.71%	22,415 $364,000
Q4 2023 Feb 14, 2024	SELL	$4.88 - $7.42 $29,621 - $45,039	-6,070 Reduced 26.73%	16,640 $113,000
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $127,861 - $190,214	-26,309 Reduced 53.67%	22,710 $123,000
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $1,056 - $1,923	186 Added 0.38%	49,019 $332,000
Q1 2023 May 16, 2023	BUY	$2.83 - $5.11 $40,183 - $72,556	14,199 Added 41.0%	48,833 $244,000
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $12,102 - $61,195	-4,034 Reduced 10.43%	34,634 $169,000
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $237,906 - $335,216	17,042 Added 78.8%	38,668 $558,000
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $105,142 - $193,527	-12,791 Reduced 37.16%	21,626 $327,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $27,097 - $72,066	4,137 Added 13.66%	34,417 $409,000
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $57,402 - $108,476	3,701 Added 13.92%	30,280 $491,000
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $292,061 - $396,679	10,632 Added 66.67%	26,579 $759,000
Q2 2021 Aug 11, 2021	SELL	$25.45 - $37.64 $85,995 - $127,185	-3,379 Reduced 17.48%	15,947 $539,000
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $364,820 - $650,071	12,511 Added 183.58%	19,326 $584,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $56,827 - $81,444	1,501 Added 28.25%	6,815 $337,000
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $2,213 - $2,748	-63 Reduced 1.17%	5,314 $204,000
Q2 2020 Aug 14, 2020	SELL	$23.66 - $49.53 $171,605 - $359,241	-7,253 Reduced 57.43%	5,377 $232,000
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $181,745 - $452,153	12,630 New	12,630 $330,000
Q4 2019 Feb 14, 2020	SELL	$23.81 - $33.78 $213,670 - $303,141	-8,974 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $193,569 - $281,514	8,974 New	8,974 $234,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

Paradigm Biocapital Advisors LP New York, NY

4.09M
Shares

$33.3 Million
1.93% of portfolio
Black Rock Inc. New York, NY

2.94M
Shares

$24 Million
0.0% of portfolio
Sofinnova Investments, Inc. Menlo Park, CA

2.19M
Shares

$17.9 Million
2.73% of portfolio
Vanguard Group Inc Valley Forge, PA

2.04M
Shares

$16.6 Million
0.0% of portfolio
Polar Capital Holdings PLC London, X0

1.83M
Shares

$14.9 Million
0.15% of portfolio

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account